CEBPB and liver cancer: Furthermore, the accumulation of enhancer hypomethylation has been shown to correlate with the likelihood of metastasis and poor prognosis in lung,55 breast,56 and liver cancer, where hypomethylation of enhancers targeted by CCAAT/enhancer-binding protein-beta correlates with poor outcomes.57